rs772602
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_012128.4(CLCA4):c.954+227C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.546 in 151,764 control chromosomes in the GnomAD database, including 23,964 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.55 ( 23964 hom., cov: 31)
Consequence
CLCA4
NM_012128.4 intron
NM_012128.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.184
Publications
2 publications found
Genes affected
CLCA4 (HGNC:2018): (chloride channel accessory 4) The protein encoded by this gene belongs to the calcium sensitive chloride conductance protein family. To date, all members of this gene family map to the same site on chromosome 1p31-p22 and share high degrees of homology in size, sequence and predicted structure, but differ significantly in their tissue distributions. Alternative splicing results in multiple transcript variants, only one of which is thought to be protein coding. [provided by RefSeq, Dec 2008]
CLCA4 Gene-Disease associations (from GenCC):
- cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.703 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CLCA4 | NM_012128.4 | c.954+227C>T | intron_variant | Intron 6 of 13 | ENST00000370563.3 | NP_036260.2 | ||
| CLCA4 | NR_024602.2 | n.887+227C>T | intron_variant | Intron 5 of 12 | ||||
| CLCA4 | XM_011541015.3 | c.801+227C>T | intron_variant | Intron 6 of 13 | XP_011539317.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.546 AC: 82837AN: 151648Hom.: 23944 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
82837
AN:
151648
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.546 AC: 82886AN: 151764Hom.: 23964 Cov.: 31 AF XY: 0.554 AC XY: 41088AN XY: 74164 show subpopulations
GnomAD4 genome
AF:
AC:
82886
AN:
151764
Hom.:
Cov.:
31
AF XY:
AC XY:
41088
AN XY:
74164
show subpopulations
African (AFR)
AF:
AC:
14363
AN:
41394
American (AMR)
AF:
AC:
10082
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
AC:
2132
AN:
3464
East Asian (EAS)
AF:
AC:
3716
AN:
5146
South Asian (SAS)
AF:
AC:
3369
AN:
4818
European-Finnish (FIN)
AF:
AC:
6572
AN:
10538
Middle Eastern (MID)
AF:
AC:
142
AN:
294
European-Non Finnish (NFE)
AF:
AC:
40666
AN:
67850
Other (OTH)
AF:
AC:
1137
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1797
3594
5392
7189
8986
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2284
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.